tradingkey.logo
搜索

Anbio Biotechnology

NNNN
添加自选
9.900USD
-0.850-7.91%
收盘 07-31 16:00美东报价延迟15分钟
434.52M总市值
67.52市盈率 TTM

关于 Anbio Biotechnology 公司

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Anbio Biotechnology简介

公司代码NNNN
公司名称Anbio Biotechnology
上市日期Feb 19, 2025
CEOLau (Michael)
员工数量27
证券类型Ordinary Share
年结日Feb 19
公司地址Friedrich-Ebert-Anlage 49
城市FRANKFURT AM MAIN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Germany
邮编60308
电话4916096247281
网址https://anbiobiotechnology.com/
公司代码NNNN
上市日期Feb 19, 2025
CEOLau (Michael)

Anbio Biotechnology公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

常见问题

Anbio Biotechnology的前五大股东是谁?

Anbio Biotechnology 的前五大股东如下:Mr. Michael Lau

有多少机构持有Anbio Biotechnology(NNNN)的股份?

截至2026Q1,共有13家机构持有Anbio Biotechnology的股份,合计持有的股份价值约为2.13M,占公司总股份的4.86%。与2025Q4相比,机构持股有所增加,增幅为2063041.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有